Section one: Contracting authority
one.1) Name and addresses
Medicines Discovery Catapult
Block 35, Mereside, Alderley Park
Cheshire
SK10 4ZF
Contact
Mr Kieran McGowan
Kieran.McGowan@md.catapult.org.uk
Telephone
+44 1625708394
Country
United Kingdom
NUTS code
UKD62 - Cheshire East
Internet address(es)
Main address
Buyer's address
one.3) Communication
Additional information can be obtained from the above-mentioned address
one.4) Type of the contracting authority
Other type
Research - Drug Discovery / Health
one.5) Main activity
Other activity
Research - Drug Discovery / Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
PIN: Laboratory Equipment Future Opportunity
Reference number
DN559116
two.1.2) Main CPV code
- 38000000 - Laboratory, optical and precision equipments (excl. glasses)
two.1.3) Type of contract
Supplies
two.1.4) Short description
Medicines Discovery Catapult (MDC) is a national facility for collaborative R&D exploring and developing new approaches to the discovery and proof of well targeted medicines, diagnostics and biomarkers. Funded by Innovate UK, an agency of the UK government, MDC are an independent not-for-profit company bringing together a fragmented UK sector of industry, academia, charities, technologists, services, finance companies, SMEs and start-ups who together can turn good science into new, high value products. By sharing problems, rare expertise and assets we support the growth of this new community through a time of radical business and national change.
Capitalising on the success of the Lighthouse Laboratory to create a new facility for innovative diagnostics, biomarkers and complex medicines and develop the UK’s onshore diagnostic capability and capacity and the associated supply chain – Translational Research for Infectious Diseases (TRFID). The project will create a national facility for testing and validation of new diagnostics, biomarkers and innovative therapeutics for disease.
This prior information notice (PIN) is a signal of future intentions to the marketplace regarding the procurement of equipment for the TRFID facility. This PIN is not a call for competition. By publishing this PIN, MDC may avail itself of the opportunity to reduce the submission period from 30 days (with electronic submission) to 15 days (if the PIN has been published for at least 35 days and no longer than 12 months).
A list of the equipment that may be required is attached with this PIN. Please note that this list may change as requirements are altered. It is appreciated that new items cannot be added to the list, but it may be the case that some items are removed following review.
It is envisaged that individual invitations to tender (ITT) exercises will be conducted for each of the elements identified on the list.
This notice is for prior information.
This notice aims at reducing time limits for receipt of tenders.
PIN Questionnaire: https://procontract.due-north.com/RFx/RFxSummary?rfxId=e8bb934e-dbf5-eb11-810d-005056b64545
two.1.6) Information about lots
This contract is divided into lots: No
two.2) Description
two.2.3) Place of performance
NUTS codes
- UKD62 - Cheshire East
two.2.4) Description of the procurement
Medicines Discovery Catapult (MDC) is a national facility for collaborative R&D exploring and developing new approaches to the discovery and proof of well targeted medicines, diagnostics and biomarkers. Funded by Innovate UK, an agency of the UK government, MDC are an independent not-for-profit company bringing together a fragmented UK sector of industry, academia, charities, technologists, services, finance companies, SMEs and start-ups who together can turn good science into new, high value products. By sharing problems, rare expertise and assets we support the growth of this new community through a time of radical business and national change.
Capitalising on the success of the Lighthouse Laboratory to create a new facility for innovative diagnostics, biomarkers and complex medicines and develop the UK’s onshore diagnostic capability and capacity and the associated supply chain – Translational Research for Infectious Diseases (TRFID). The project will create a national facility for testing and validation of new diagnostics, biomarkers and innovative therapeutics for disease.
This prior information notice (PIN) is a signal of future intentions to the marketplace regarding the procurement of equipment for the TRFID facility. This PIN is not a call for competition. By publishing this PIN, MDC may avail itself of the opportunity to reduce the submission period from 30 days (with electronic submission) to 15 days (if the PIN has been published for at least 35 days and no longer than 12 months).
A list of the equipment that may be required is attached with this PIN. Please note that this list may change as requirements are altered. It is appreciated that new items cannot be added to the list, but it may be the case that some items are removed following review.
It is envisaged that individual invitations to tender (ITT) exercises will be conducted for each of the elements identified on the list.
This notice is for prior information.
This notice aims at reducing time limits for receipt of tenders.
PIN Questionnaire: https://procontract.due-north.com/RFx/RFxSummary?rfxId=e8bb934e-dbf5-eb11-810d-005056b64545
two.3) Estimated date of publication of contract notice
31 August 2021
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
PIN: Laboratory Equipment Future Opportunity
two.1.2) Main CPV code
- 38000000 - Laboratory, optical and precision equipments (excl. glasses)
two.1.3) Type of contract
Supplies
two.1.4) Short description
Medicines Discovery Catapult (MDC) is a national facility for collaborative R&D exploring and developing new approaches to the discovery and proof of well targeted medicines, diagnostics and biomarkers. Funded by Innovate UK, an agency of the UK government, MDC are an independent not-for-profit company bringing together a fragmented UK sector of industry, academia, charities, technologists, services, finance companies, SMEs and start-ups who together can turn good science into new, high value products. By sharing problems, rare expertise and assets we support the growth of this new community through a time of radical business and national change.
Capitalising on the success of the Lighthouse Laboratory to create a new facility for innovative diagnostics, biomarkers and complex medicines and develop the UK’s onshore diagnostic capability and capacity and the associated supply chain – Translational Research for Infectious Diseases (TRFID). The project will create a national facility for testing and validation of new diagnostics, biomarkers and innovative therapeutics for disease.
This prior information notice (PIN) is a signal of future intentions to the marketplace regarding the procurement of equipment for the TRFID facility. This PIN is not a call for competition. By publishing this PIN, MDC may avail itself of the opportunity to reduce the submission period from 30 days (with electronic submission) to 15 days (if the PIN has been published for at least 35 days and no longer than 12 months).
A list of the equipment that may be required is attached with this PIN. Please note that this list may change as requirements are altered. It is appreciated that new items cannot be added to the list, but it may be the case that some items are removed following review.
It is envisaged that individual invitations to tender (ITT) exercises will be conducted for each of the elements identified on the list.
This notice is for prior information.
This notice aims at reducing time limits for receipt of tenders.
https://procontract.due-north.com/RFx/RFxSummary?rfxId=e8bb934e-dbf5-eb11-810d-005056b64545
two.1.6) Information about lots
This contract is divided into lots: No
two.2) Description
two.2.3) Place of performance
NUTS codes
- UKD62 - Cheshire East
two.2.4) Description of the procurement
Medicines Discovery Catapult (MDC) is a national facility for collaborative R&D exploring and developing new approaches to the discovery and proof of well targeted medicines, diagnostics and biomarkers. Funded by Innovate UK, an agency of the UK government, MDC are an independent not-for-profit company bringing together a fragmented UK sector of industry, academia, charities, technologists, services, finance companies, SMEs and start-ups who together can turn good science into new, high value products. By sharing problems, rare expertise and assets we support the growth of this new community through a time of radical business and national change.
Capitalising on the success of the Lighthouse Laboratory to create a new facility for innovative diagnostics, biomarkers and complex medicines and develop the UK’s onshore diagnostic capability and capacity and the associated supply chain – Translational Research for Infectious Diseases (TRFID). The project will create a national facility for testing and validation of new diagnostics, biomarkers and innovative therapeutics for disease.
This prior information notice (PIN) is a signal of future intentions to the marketplace regarding the procurement of equipment for the TRFID facility. This PIN is not a call for competition. By publishing this PIN, MDC may avail itself of the opportunity to reduce the submission period from 30 days (with electronic submission) to 15 days (if the PIN has been published for at least 35 days and no longer than 12 months).
A list of the equipment that may be required is attached with this PIN. Please note that this list may change as requirements are altered. It is appreciated that new items cannot be added to the list, but it may be the case that some items are removed following review.
It is envisaged that individual invitations to tender (ITT) exercises will be conducted for each of the elements identified on the list.
This notice is for prior information.
This notice aims at reducing time limits for receipt of tenders.
https://procontract.due-north.com/RFx/RFxSummary?rfxId=e8bb934e-dbf5-eb11-810d-005056b64545
two.3) Estimated date of publication of contract notice
31 August 2021
Section four. Procedure
four.1) Description
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: Yes